European Chemical Industry News & Insights

Jazz Pharmaceuticals Begins Construction on New Facility in Ireland

At a glance
  • The new facility in Roscommon will cost $60-$68 million.
  • Construction is expected to be completed by 2016.
  • The project will create 160 construction jobs and 50 permanent jobs.
  • Supported by IDA Ireland and the Irish Government's Department of Jobs, Enterprise and Innovation.

Project Overview

Jazz Pharmaceuticals has started construction on a new manufacturing and development facility in Monksland, County Roscommon, Ireland. This is the company's first manufacturing facility, located approximately 75 miles east of its Dublin headquarters.

Investment and Timeline

The facility will cost between $60 and $68 million (€45 – €50 million) and is expected to be completed by 2016. The investment covers construction, development, and personnel costs for the 55,000 ft² (5,100 m²) facility.

Job Creation

The project will create 160 jobs during the construction phase and up to 50 permanent jobs once the facility is fully operational. This development is seen as a significant boost for the local area, providing opportunities for those who have lost jobs in recent years.

Support and Collaboration

The investment is supported by Ireland's Industrial Development Authority (IDA Ireland) and the Irish Government's Department of Jobs, Enterprise and Innovation. The ground-breaking ceremony was attended by key figures, including the Taoiseach (Prime Minister) of Ireland, Mr. Enda Kenny TD, and Mr. Barry O'Leary, CEO of IDA Ireland.